Longevity Activator
Retirée du marché américain le 23 September 2024 (selon le DSLD)
Zenith Labs, food supplement from the US market
Label withdrawn from the US market. Longevity Activator (Zenith Labs), a food supplement au code-barres 686162736430, is described by its US market label. If sold in France, it would be subject to 4 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- À vérifier
Pterostilbene is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
Source: Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), POL-NF-15349.
- À vérifier
Fisetin is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
Source: Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), POL-NF-16002.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/2340).
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Zenith Labs
- Barcode
- 686162736430
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Gelatin, Rice Flour, Stearic Acid, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Green Tea Leaf Extract (Camellia sinensis) | Plant | 100 mg |
| Taurine | Other substance | 100 mg |
| Chebulic Myrobalan fruit extract (Terminalia chebula) | Plant | 50 mg |
| Astragalus (Astragalus membranaceus) | Plant | 50 mg |
| Berberine Hydrochloride | Other substance | 25 mg |
| Purslane Whole Plant Extract (Portulaca oleracea) | Plant | 25 mg |
| Desert Broomrape (Cistanche deserticola) | Plant | 25 mg |
| Cordyceps sinensis Extract | Plant | 25 mg |
| Ashwagandha (Withania somnifera) | Plant | 25 mg |
| Asian Ginseng (Panax ginseng) | Plant | 25 mg |
| Turmeric (Curcuma longa) | Plant | 25 mg |
| Resveratrol | Other substance | 25 mg |
| Pterostilbene | Other substance | 25 mg |
| Fisetin | Other substance | 25 mg |
| L-Carnosine | Other substance | 10 mg |
| Absorption Support Blend | Blend | 25 mg |
| Ginger Root Extract | Plant | not stated |
| Phospholipid Concentrate | Blend | not stated |
| Bioperine (Piper nigrum) | Plant | not stated |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Longevity Activator
Entered into DSLD on 25 March 2025. En vente sur le marché américain (selon le DSLD).- Active ingredient added : Arjuna Bark Extract, Powder (50 mg)
- Active ingredient added : Ashwagandha, Powder (25 mg)
- Active ingredient added : Astragalus, Powder (50 mg)
- Active ingredient added : Barberry Root Extract (25 mg)
- Active ingredient added : Cordyceps Mushroom, Powder (25 mg)
- Active ingredient added : Panax ginseng, Powder (25 mg)
- Active ingredient added : Silbinol (25 mg)
- Active ingredient added : Trans-Resveratrol (25 mg)
- Active ingredient added : Turmeric, Powder (25 mg)
- Active ingredient removed : Ashwagandha (25 mg)
- Active ingredient removed : Asian Ginseng (25 mg)
- Active ingredient removed : Astragalus (50 mg)
- Active ingredient removed : Berberine Hydrochloride (25 mg)
- Active ingredient removed : Chebulic Myrobalan fruit extract (50 mg)
- Active ingredient removed : Cordyceps sinensis Extract (25 mg)
- Active ingredient removed : Pterostilbene (25 mg)
- Active ingredient removed : Resveratrol (25 mg)
- Active ingredient removed : Turmeric (25 mg)
- Same quantity, different name: Green Tea Extract in this version; Green Tea Leaf Extract on the displayed label (100 mg)
- Same quantity, different name: Sunflower Oil, Powder in this version; Phospholipid Concentrate on the displayed label (quantity not stated)
Official label: Longevity Activator
Entered into DSLD on 13 December 2022. Retirée du marché américain le 23 September 2024 (selon le DSLD).- Active ingredient added : Cistanche deserticola (25 mg)
- Active ingredient added : Korean Ginseng (25 mg)
- Active ingredient removed : Asian Ginseng (25 mg)
- Active ingredient removed : Desert Broomrape (25 mg)
- Same quantity, different name: Terminalia chebula fruit extract in this version; Chebulic Myrobalan fruit extract on the displayed label (50 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Astragalus
Read the warning, when it applies and the studies cited
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Ashwagandha
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Asian Ginseng
Read the warning, when it applies and the studies cited
PANAX GINSENG
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Turmeric
Read the warning, when it applies and the studies cited
TURMERIC - CURCUMA LONGA - Oral
Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000)
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).
5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All uses except for Source of antioxidants and Hepatoprotectant.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 26 September 2025
Turmeric -CURCUMA LONGA - Topical
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Zenith Labs
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.